Trial intelligence / Profile preview

Ablation and Qilisheng for Unresectable Intestinal Cancer

NCT03350490Phase 3Completed

Sponsor
Fuda Cancer Hospital
Start
Nov 2017
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Life information rehabilitation therapy in intestinal cancer, sponsored by Fuda Cancer Hospital. Started Nov 2017; status: completed.

02

Drugs

Life information rehabilitation therapy
03

Conditions

intestinal cancer

Beyond the preview

Go deeper on NCT03350490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03350490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call